Benefit-Risk Analysis of Buprenorphine for Pain Management

Health care providers in the United States are facing challenges in selecting appropriate medication for patients with acute and chronic pain in the midst of the current opioid crisis and COVID-19 pandemic. When compared with conventional opioids, the partial µ-opioid receptor agonist buprenorphine...

Descripción completa

Detalles Bibliográficos
Autores principales: Hale, Martin, Garofoli, Mark, Raffa, Robert B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163969/
https://www.ncbi.nlm.nih.gov/pubmed/34079354
http://dx.doi.org/10.2147/JPR.S305146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163969/
https://www.ncbi.nlm.nih.gov/pubmed/34079354
http://dx.doi.org/10.2147/JPR.S305146

Ejemplares similares